News
SURNF
--
NaN%
--
SureNano Science Enters LOI to Acquire GlucaPharm for GLP-1 Drug Development
Reuters · 11/19 21:31
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
Newsfile · 11/19 21:30
SureNano Science to raise $1.25M via private placement
Seeking Alpha · 11/06 10:20
SureNano Science Launches $1.25 Million Private Placement
Reuters · 11/05 23:37
SureNano Announces Private Placement
Newsfile · 11/05 23:36
SureNano Closes Financing
Newsfile · 09/19 20:30
SureNano Science Ltd. Held Annual General and Special Meeting
Reuters · 08/22 13:01
SureNano Announces Funding, Debt Settlement and AGSM Results
Newsfile · 08/22 13:00
More
Webull provides a variety of real-time SURNF stock news. You can receive the latest news about SureNano Science through multiple platforms. This information may help you make smarter investment decisions.
About SURNF
SureNano Science Ltd. is a Canada-based company. The principal business of the Company is the sale and distribution of the SureNano surfactant, which is a ready-to-mix food grade compound that provides the base for high performance nano-emulsions to create incredibly homogeneous and stable products while maximizing bioavailability, clarity and taste. The Company has licenses to distribute the SureNano surfactant within Canada, the State of Oklahoma, United States, and the State of Colorado, United States. SureNano includes Free Flavor technology designed specifically to reduce the naturally bitter notes of many cannabinoids included Cannabidiol (CBD) and tetrahydrocannabinol (THC).